Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Differentiation of central lung cancer from atelectasis: comparison of diffusion-weighted MRI with PET/CT.

Yang RM, Li L, Wei XH, Guo YM, Huang YH, Lai LS, Chen AM, Liu GS, Xiong WF, Luo LP, Jiang XQ.

PLoS One. 2013 Apr 4;8(4):e60279. doi: 10.1371/journal.pone.0060279. Print 2013.

2.

Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study.

Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY.

Eur Radiol. 2009 Feb;19(2):333-41. doi: 10.1007/s00330-008-1134-3. Epub 2008 Aug 9.

PMID:
18690450
3.

Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.

Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S.

Eur J Radiol. 2012 Jan;81(1):178-82. doi: 10.1016/j.ejrad.2010.09.001. Epub 2010 Oct 6.

PMID:
20932700
4.

Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma.

Baysal T, Mutlu DY, Yologlu S.

Magn Reson Imaging. 2009 Dec;27(10):1447-54. doi: 10.1016/j.mri.2009.05.024. Epub 2009 Jun 24.

PMID:
19553048
5.

Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K.

Radiology. 2008 Aug;248(2):643-54. doi: 10.1148/radiol.2482072039. Epub 2008 Jun 6.

PMID:
18539889
6.

Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.

Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T.

Radiology. 2007 May;243(2):570-7. Epub 2007 Mar 30.

PMID:
17400757
7.

Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?

Regier M, Derlin T, Schwarz D, Laqmani A, Henes FO, Groth M, Buhk JH, Kooijman H, Adam G.

Eur J Radiol. 2012 Oct;81(10):2913-8. doi: 10.1016/j.ejrad.2011.11.050. Epub 2011 Dec 23.

PMID:
22197090
8.

Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience.

Guimaraes MD, Marchiori E, Odisio BC, Hochhegger B, Bitencourt AG, Zurstrassen CE, Tyng CC, Gross JL, Chojniak R, Godoy MC.

World J Surg Oncol. 2014 Jul 10;12:203. doi: 10.1186/1477-7819-12-203.

9.

Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.

Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV.

Radiology. 2010 Jan;254(1):154-62. doi: 10.1148/radiol.09090304.

PMID:
20032150
10.
11.

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.

Vargas HA, Akin O, Franiel T, Mazaheri Y, Zheng J, Moskowitz C, Udo K, Eastham J, Hricak H.

Radiology. 2011 Jun;259(3):775-84. doi: 10.1148/radiol.11102066. Epub 2011 Mar 24.

12.
13.

Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient.

Nakayama J, Miyasaka K, Omatsu T, Onodera Y, Terae S, Matsuno Y, Cho Y, Hida Y, Kaga K, Shirato H.

J Comput Assist Tomogr. 2010 Jan;34(1):1-8. doi: 10.1097/RCT.0b013e3181a9cc07.

PMID:
20118713
14.

[3.0T MR diffusion-weighted imaging: evaluating diagnosis potency of pulmonary solid benign lesions and malignant tumors and optimizing b value].

Li W, Li D, Liu H, Zhou R, Feng C, Ma Y, Yu T.

Zhongguo Fei Ai Za Zhi. 2011 Nov;14(11):853-7. doi: 10.3779/j.issn.1009-3419.2011.11.04. Chinese.

15.

Diffusion-weighted MR imaging of normal and abnormal scrotum: preliminary results.

Tsili AC, Argyropoulou MI, Giannakis D, Tsampalas S, Sofikitis N, Tsampoulas K.

Asian J Androl. 2012 Jul;14(4):649-54. doi: 10.1038/aja.2011.172. Epub 2012 Feb 27.

16.

Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.

Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, Hermans R.

Radiology. 2009 Apr;251(1):134-46. doi: 10.1148/radiol.2511080128. Epub 2009 Feb 27.

PMID:
19251938
17.

Efficiency of apparent diffusion coefficients in differentiation of colorectal tumor recurrences and posttherapeutical soft-tissue changes.

Nural MS, Danaci M, Soyucok A, Okumus NO.

Eur J Radiol. 2013 Oct;82(10):1702-9. doi: 10.1016/j.ejrad.2013.05.025. Epub 2013 Jun 17.

PMID:
23787275
18.

Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.

Wong CS, Gong N, Chu YC, Anthony MP, Chan Q, Lee HF, Chu KM, Khong PL.

Eur J Radiol. 2012 Sep;81(9):2122-6. doi: 10.1016/j.ejrad.2011.09.003. Epub 2011 Sep 28.

PMID:
21955604
19.

Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):816-22. doi: 10.1016/j.jtcvs.2007.10.035.

20.

Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?

Buchbender C, Hartung-Knemeyer V, Heusch P, Heusner TA, Beiderwellen K, Wittsack HJ, Kühl H, Forsting M, Bockisch A, Antoch G, Lanzman RS.

Eur J Radiol. 2013 Feb;82(2):380-4. doi: 10.1016/j.ejrad.2012.11.018. Epub 2012 Dec 10.

PMID:
23238361

Supplemental Content

Support Center